2021-01-05,2 Strong Buy Penny Stocks That Could Deliver Massive Returns
2020-12-21,9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
2020-12-15,"9 Meters Biopharma, Inc. Announces Closing of Offering of Common Stock"
2020-12-11,"9 Meters Biopharma, Inc. Prices Public Offering of Common Stock"
2020-12-09,"9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)"
2020-12-07,"9 Meters Biopharma, Inc. Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome"
2020-12-02,Is 9 Meters Biopharma (NMTR) A Good Stock To Buy Now?
2020-11-16,"9 Meters Biopharma Announces Positive Preclinical Data for NM-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model"
2020-11-16,"What Type Of Shareholders Own The Most Number of 9 Meters Biopharma, Inc. (NASDAQ:NMTR) Shares?"
2020-11-09,"9 Meters Biopharma, Inc. Provides Business Update and Announces Third Quarter 2020 Results"
2020-11-02,"9 Meters Biopharma, Inc. to Participate in the Following November Virtual Investor Conferences"
2020-09-08,"9 Meters Biopharma, Inc. to Participate in September Investor Conferences"
2020-08-31,"9 Meters Biopharma, Inc. Announces Formation of Scientific Advisory Board"
2020-08-13,"9 Meters Biopharma, Inc. Highlighted at Upcoming Truist Securities' Catalyst Conference Call Series: ""Prepping Ahead of Data"""
2020-08-12,"9 Meters Biopharma, Inc. Provides Business Update and Announces Second Quarter 2020 Results"
2020-08-04,"9 Meters Biopharma, Inc. to Participate in August Investor Conferences"
2020-07-28,"9 Meters Biopharma, Inc. Announces Issuance of Patent for Use of Larazotide in Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)"
2020-07-21,"9 Meters Biopharma, Inc. Doses the First Patients in Phase 1b/2a Clinical Trial in Short Bowel Syndrome"
2020-07-13,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating 9 Meters Biopharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"
2020-07-06,"9 Meters Biopharma, Inc. Appoints Michael T. Constantino to Board of Directors"
2020-07-02,"9 Meters Biopharma, Inc. to Participate in BMO Capital Markets' ""Hidden Gems in Healthcare Conference Call Series"""
2020-06-29,"9 Meters Biopharma, Inc. Amends Definition of Primary Endpoint for Phase 3 Trial in Celiac Disease After Consultation with FDA"
2020-06-24,"9 Meters Biopharma, Inc. Initiates Phase 1b/2a Clinical Trial in Short Bowel Syndrome"
2020-05-11,"9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease"
2020-05-07,"9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition"
2020-05-05,9 Meters Biopharma Hosting Research and Development Day
2020-05-04,"9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding"
